A GMP Deviation refers to any departure from approved manufacturing procedures, specifications, or regulatory requirements during pharmaceutical production. Deviations may arise from equipment malfunction, human error, or process variability and require formal investigation.
The biopharmaceutical industry manages deviations through structured quality systems assessing root causes, product impact, and corrective actions. Regulatory agencies expect timely documentation and risk-based evaluation of deviations. Effective deviation management supports continuous improvement and maintains compliance while protecting product quality and patient safety. Trending analyses identify recurring issues enabling proactive corrective action to prevent reoccurrence.
Quality & Compliance
GMP Deviation
A GMP deviation is any departure from an approved manufacturing procedure, specification or quality requirement that must be investigated and documented.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →